NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Pharmaceutical firms are increasingly turning their marketing force into teams of specialists, because a generalist medical representative may find it tough to explain to a doctor the complex and high-margin drugs they are pushing. Pfizer, Sun Pharmaceutical Industries, Abbott, Dr Reddy's Laboratories, Cipla, Lupin, Glenmark Pharmaceuticals, Mankind Pharma, Torrent Pharmaceuticals,…

news

The state's biggest biotech employer, Genzyme Corp., is building a new, 251,000 square foot headquarters a few blocks away from its current location and plans to move there in three years. Bo Piela, vice president of communications for Genzyme, the rare disease subsidiary of French drug giant, Sanofi (NYSE: SFY),…

news

The pharmaceutical industry claims that 500 jobs have been lost as a result of the Government's drug-pricing policies. The Department of Jobs, Enterprise, and Innovation said there is "no evidence" for the claim, which is contained in correspondence between the Irish Pharmaceutical Healthcare Association and the Department of Health seen…

news

Japan's Fujifilm Holdings Corp said on Monday it has agreed to acquire U.S. biotechnology firm Cellular Dynamics International Inc (CDI)for $307 million. Under the deal, which was approved by both companies' boards, Fujifilm will make a tender offer for all of CDI for $16.5 per share, the Japanese firm said…

news

Teva Pharmaceutical is buying Auspex Pharmaceuticals for about $3.2 billion in a move to strengthen its position on central nervous system condition treatments. Jerusalem-based Teva said Monday that it will pay $101 per share, marking a 47 percent premium to San Diego-based Auspex's closing stock price on Friday. Auspex does…

news

The United States Food and Drug Administration rejected Adamis Pharmaceuticals Corp's injection for treating severe allergic reactions, the company said on Friday. The pre-filled epinephrine injection, is being developed to treat acute anaphylaxis, a severe allergic reaction that can cause death. Adamis said the questions raised by the FDA largely…

news

A group of the world's leading drugmakers have joined the U.K.'s ambitious initiative to sequence the genomes of 100,000 Britons, mining the data with hopes of finding new pathways to treat cancer and rare diseases. Under a yearlong project, the researchers at Genomics England are bringing in some industry heavyweights…

news

Conatus Pharmaceuticals Inc said its experimental lead drug was more effective than a placebo in a mid-stage study in patients with a form of fatty liver disease. The company's stock soared more than 50 percent before the bell on Thursday. The drug, emricasan, was tested in 38 patients with non-alcoholic…

news

Germany is a mature market with high healthcare expenditure and pharmaceutical production but future growth could be potentially hindered by cost-saving government policies. The pharmaceutical market in Germany is valued at $58.6 billion in 2014, according to research and consulting firm GlobalData. Despite its position as the leading pharmaceutical market…

news

Drug major Cipla today announced the launch of generic drug Sofosbuvir for treating chronic Hepatitis C under the brand name 'Hepcvir', in India. "Following the non-exclusive licensing agreement signed with Gilead Sciences in September last year to manufacture and market chronic Hepatitis C medicines, Cipla is now all set to…